Pancreatic Enzyme Supplements — MCQs
What are the indications for surgical intervention in a patient with pancreatic ascites?
In a patient with lipoprotein lipase deficiency, which of the following is increased following a fatty meal?
Which of the following drugs is associated with an untoward side effect of renal tubular damage?
A young boy presents with failure to thrive. Biochemical analysis of a duodenal aspirate after a meal reveals a deficiency of enteropeptidase (enterokinase). Which one of the following digestive enzymes would be affected by this deficiency?
At which positions does pancreatic lipase hydrolyze the ester linkages of triacylglycerides?
Which of the following is the most common adverse effect of omeprazole?
Which is not a component of Ranson's criteria for acute pancreatitis?
A 4-year-old boy is admitted to the hospital with pneumonia and respiratory distress. The nurses report that the child's bowel movements are greasy and have a pungent odor. A sweat-chloride test is positive. Which of the following mechanisms of disease is the most likely cause of steatorrhea in this child?
Enteropeptidase enzyme is secreted by:
Mechanism of action of cholecystokinin?
Pancreatic Enzyme Supplements Indian Medical PG Practice Questions and MCQs
Question 1: What are the indications for surgical intervention in a patient with pancreatic ascites?
- A. Initial leak from stented duct
- B. Persistent leak from a stented duct (Correct Answer)
- C. Persistent symptoms despite medical management
- D. Recurrent ascites after drainage with ongoing symptoms
Explanation: **Persistent leak from a stented duct** - This indicates that **endoscopic drainage** or stenting has failed to resolve the pancreatic duct leak, requiring a more definitive surgical approach. - **Ongoing leakage** despite internal drainage attempts suggests a persistent anatomical disruption that only surgery can effectively repair. *Persistent symptoms despite medical management* - While persistent symptoms warrant further intervention, this option is too broad and does not specifically point to the failure of less invasive procedures like endoscopic stenting. - Symptoms alone, without evidence of a failed specific intervention, might lead to other non-surgical interventions first. *Initial leak from stented duct* - An initial leak is often managed with **endoscopic stent placement** as the primary, less invasive intervention. - Surgical intervention is typically reserved for cases where initial stenting and conservative measures fail. *Recurrent ascites after drainage with ongoing symptoms* - **Recurrent ascites** after simple drainage (paracentesis) only suggests a persistent leak, but this option does not mention the failure of a stented duct. - The next step after drainage would likely be **endoscopic retrograde cholangiopancreatography (ERCP)** and stenting before considering surgery.
Question 2: In a patient with lipoprotein lipase deficiency, which of the following is increased following a fatty meal?
- A. Chylomicron (Correct Answer)
- B. LDL
- C. HDL
- D. Apo-A
Explanation: ***Chylomicron*** - Lipoprotein lipase (LPL) is essential for the breakdown of **chylomicrons** in the bloodstream. A deficiency in LPL means chylomicrons cannot be cleared effectively. - After a **fatty meal**, the body absorbs dietary fats as chylomicrons. Without functional LPL, these chylomicrons accumulate in the plasma, leading to **marked elevation** of chylomicron levels. - This results in **lipemic (milky) serum**, a characteristic finding in Type I hyperlipoproteinemia. *LDL* - **LDL (Low-Density Lipoprotein)** levels are primarily affected by the metabolism of VLDL (Very Low-Density Lipoprotein), which is a separate pathway from chylomicron metabolism. - LPL deficiency specifically impacts chylomicron clearance, not directly causing an increase in LDL. In fact, LDL may be normal or even low in severe hypertriglyceridemia. *HDL* - **HDL (High-Density Lipoprotein)** is involved in reverse cholesterol transport and is typically **decreased** (not increased) in LPL deficiency. - During normal lipolysis by LPL, surface components from chylomicrons are transferred to HDL. In LPL deficiency, this process is impaired, leading to **reduced HDL levels**. *Apo-A* - **Apolipoprotein A-I (Apo-AI)** is the primary apolipoprotein found on HDL particles and is crucial for HDL formation and function. - Since HDL levels are decreased in LPL deficiency, Apo-AI levels would also be decreased (not increased) following a fatty meal.
Question 3: Which of the following drugs is associated with an untoward side effect of renal tubular damage?
- A. Cisplatin (Correct Answer)
- B. Streptozocin
- C. Methysergide
- D. Cyclophosphamide
Explanation: ***Cisplatin*** - **Cisplatin** is the **classic and most prominent example** of a drug causing **direct renal tubular damage**, specifically **acute tubular necrosis (ATN)** - Nephrotoxicity is **dose-limiting** and occurs in up to 30% of patients, making it the hallmark side effect - Mechanism: Direct toxic injury to proximal and distal tubular epithelial cells with mitochondrial dysfunction - Results in reduced GFR, electrolyte disturbances (hypomagnesemia, hypokalemia), and potentially irreversible renal impairment - **Most closely associated** with the term "renal tubular damage" in medical education *Streptozocin* - Streptozocin is also nephrotoxic and can cause proximal tubular dysfunction - However, it manifests more specifically as **Fanconi syndrome** (glycosuria, phosphaturia, aminoaciduria) rather than the classic acute tubular necrosis pattern - Its toxicity profile is more complex, affecting both pancreatic beta cells and renal tubules - While it causes tubular dysfunction, it is **not the primary drug** associated with direct tubular damage in standard teaching *Methysergide* - Methysergide causes **retroperitoneal fibrosis**, not direct renal tubular damage - Kidney injury occurs **indirectly** through ureteral obstruction and compression - Does not cause intrinsic tubular cell injury *Cyclophosphamide* - Primary toxicity is **hemorrhagic cystitis** due to acrolein metabolite affecting the bladder - Does not cause significant direct renal tubular damage - Renal effects are minimal compared to bladder toxicity, which can be prevented with hydration and mesna
Question 4: A young boy presents with failure to thrive. Biochemical analysis of a duodenal aspirate after a meal reveals a deficiency of enteropeptidase (enterokinase). Which one of the following digestive enzymes would be affected by this deficiency?
- A. Amylase
- B. Pepsin
- C. Trypsin (Correct Answer)
- D. Lactase
Explanation: ***Trypsin*** - Enteropeptidase (enterokinase) is crucial for activating **trypsinogen** into its active form, **trypsin**. Without active trypsin, the entire cascade of pancreatic protease activation is disrupted. - Trypsin then activates other pancreatic proteases like chymotrypsin, elastase, and carboxypeptidases, all of which are essential for **protein digestion** in the small intestine. *Amylase* - **Amylase** is a carbohydrate-digesting enzyme, primarily involved in breaking down starch. Its activity is independent of enteropeptidase. - **Pancreatic amylase** is secreted in its active form and does not require proteolytic cleavage by trypsin for activation. *Pepsin* - **Pepsin** is an enzyme found in the stomach that initiates protein digestion. It is activated by **hydrochloric acid** from its inactive precursor, pepsinogen. - Its activity is entirely independent of enteropeptidase, which functions in the duodenum. *Lactase* - **Lactase** is a brush border enzyme located in the small intestine that digests the disaccharide **lactose** into glucose and galactose. - Its production and activity are genetically regulated and not dependent on the protein-digesting enzymes or enteropeptidase.
Question 5: At which positions does pancreatic lipase hydrolyze the ester linkages of triacylglycerides?
- A. 1 and 2
- B. 2 and 3
- C. Only 3
- D. 1 and 3 (Correct Answer)
Explanation: **Correct: 1 and 3** - Pancreatic lipase specifically targets the **ester bonds at the sn-1 and sn-3 positions** (primary alcohol positions) on the glycerol backbone of triacylglycerides. - This positional specificity results in the formation of **2-monoacylglycerol (2-MAG)** and **two free fatty acids**. - This is the characteristic action of pancreatic triacylglycerol lipase during fat digestion in the intestinal lumen. *Incorrect: 1 and 2* - Hydrolysis at positions 1 and 2 would produce a 3-monoacylglycerol and free fatty acids, which is not the physiological product of pancreatic lipase. - The enzyme's positional specificity favors the outer sn-1 and sn-3 positions, not the middle sn-2 position. *Incorrect: 2 and 3* - Hydrolysis at positions 2 and 3 would yield a 1-monoacylglycerol and free fatty acids, which does not reflect pancreatic lipase activity. - The enzyme specifically spares the sn-2 position due to its structural specificity. *Incorrect: Only 3* - If only position 3 were hydrolyzed, the product would be a 1,2-diacylglycerol and one free fatty acid. - This represents incomplete hydrolysis; pancreatic lipase typically hydrolyzes **both outer positions (sn-1 and sn-3)** due to its regiospecificity.
Question 6: Which of the following is the most common adverse effect of omeprazole?
- A. Headache (Correct Answer)
- B. Constipation
- C. Liver dysfunction
- D. Upper gastrointestinal bleeding
Explanation: ***Headache*** - **Headache** is the most frequently reported adverse effect of omeprazole and other proton pump inhibitors (PPIs), occurring in approximately 2-7% of patients. - While generally mild and self-limiting, it is the most common reason for patients to report side effects during PPI therapy. - Other common adverse effects include diarrhea, nausea, and abdominal pain, but headache remains the most prevalent. *Constipation* - Constipation can occur with omeprazole use, but it is less common than headache or diarrhea. - Gastrointestinal side effects like constipation typically occur in a smaller proportion of patients compared to headache. *Liver dysfunction* - Mild **transient elevation of liver enzymes** can occur with omeprazole, but clinically significant liver dysfunction is rare. - Routine monitoring of liver function is generally not required unless there is pre-existing hepatic impairment. *Upper gastrointestinal bleeding* - Omeprazole is used to **treat and prevent** upper gastrointestinal bleeding by reducing gastric acid secretion in conditions like peptic ulcers and erosive esophagitis. - It is a therapeutic agent for this condition, not a causative factor.
Question 7: Which is not a component of Ranson's criteria for acute pancreatitis?
- A. Serum lipase (Correct Answer)
- B. Age
- C. Base deficit
- D. Blood glucose
Explanation: ***Serum lipase*** - **Serum lipase** is not a component of Ranson's criteria. While it is a crucial diagnostic marker for acute pancreatitis, Ranson's criteria focus on other clinical and laboratory values for predicting severity. - The criteria were developed before widespread availability and use of lipase as a primary diagnostic marker for pancreatitis. *Age* - **Age** is a component of Ranson's criteria, specifically "Age > 55 years" for admission and initial assessment [1]. - Older age is associated with increased severity and mortality in acute pancreatitis due to decreased physiologic reserve [1]. *Base deficit* - **Base deficit** is a component of Ranson's criteria, specifically "Base deficit > 4 mEq/L" after 48 hours. - A significant base deficit indicates **metabolic acidosis**, which is a marker of severe systemic inflammation and organ dysfunction in acute pancreatitis. *Blood glucose* - **Blood glucose** is a component of Ranson's criteria, specifically "Blood glucose > 200 mg/dL (11.1 mmol/L)" for admission and initial assessment. - Elevated blood glucose can reflect the severity of pancreatic inflammation and insult to the **islet cells**, or systemic stress response.
Question 8: A 4-year-old boy is admitted to the hospital with pneumonia and respiratory distress. The nurses report that the child's bowel movements are greasy and have a pungent odor. A sweat-chloride test is positive. Which of the following mechanisms of disease is the most likely cause of steatorrhea in this child?
- A. Abnormal dietary intake
- B. Lack of pancreatic enzyme secretion (Correct Answer)
- C. Hyperbilirubinemia with kernicterus
- D. Bacterial overgrowth
Explanation: ***Lack of pancreatic enzyme secretion*** - The clinical picture of **pneumonia**, **respiratory distress**, **greasy/pungent bowel movements (steatorrhea)**, and a **positive sweat chloride test** is classic for **cystic fibrosis (CF)**. - In CF, a defective **CFTR protein** leads to thick, viscous secretions that block pancreatic ducts, causing **pancreatic insufficiency** and leading to inadequate release of digestive enzymes necessary for fat absorption. *Abnormal dietary intake* - While dietary factors can contribute to digestive issues, abnormal intake alone would not explain the other core features like the **positive sweat chloride test** or recurrent respiratory infections characteristic of cystic fibrosis. - This mechanism doesn't account for the fundamental physiological defect seen in this patient. *Hyperbilirubinemia with kernicterus* - **Kernicterus** is a condition caused by very high levels of **bilirubin** in a newborn's blood, leading to brain damage; it is not typically associated with steatorrhea or the respiratory symptoms described. - While CF can sometimes cause liver complications, **kernicterus** is unrelated to the primary mechanism of steatorrhea in this context. *Bacterial overgrowth* - **Bacterial overgrowth** in the small intestine can cause malabsorption and diarrhea, but it does not directly lead to the specific findings of **respiratory distress**, recurrent infections, or the underlying genetic defect indicated by a **positive sweat chloride test** in cystic fibrosis. - This condition is not the primary cause of the systemic and pancreatic issues described.
Question 9: Enteropeptidase enzyme is secreted by:
- A. Ileum
- B. Duodenum (Correct Answer)
- C. Stomach
- D. Jejunum
Explanation: ***Duodenum*** - **Enteropeptidase** (also known as enterokinase) is a key enzyme primarily secreted by the mucosal cells of the **duodenum**. - Its main function is to activate **trypsinogen** (from the pancreas) into **trypsin**, initiating a cascade of protein digestion. *Ileum* - The ileum is primarily involved in the absorption of **vitamin B12** and **bile salts**. - It does not significantly contribute to the secretion of digestive enzymes like enteropeptidase. *Stomach* - The stomach secretes **pepsin** (to digest proteins) and **hydrochloric acid**, and is involved in initial protein digestion. - It does not produce enteropeptidase, which acts much later in the digestive process. *Jejunum* - The jejunum is a major site for the absorption of **nutrients** like carbohydrates, fats, and proteins. - While it has some brush border enzymes, the primary secretion of enteropeptidase occurs in the duodenum.
Question 10: Mechanism of action of cholecystokinin?
- A. Activation of adenylyl cyclase
- B. Opening of ion channels
- C. Through IP3- DAG system (Correct Answer)
- D. Transcription factors
Explanation: ***Through IP3- DAG system*** - Cholecystokinin (CCK) primarily acts via **Gq protein-coupled receptors**, leading to the activation of **phospholipase C**. - This activation results in the hydrolysis of **PIP2 into IP3 and DAG**, which then mediate intracellular signaling cascades, causing actions like gallbladder contraction and pancreatic enzyme secretion. *Activation of adenylyl cyclase* - This mechanism is typically associated with **Gs protein-coupled receptors**, leading to increased levels of **cyclic AMP (cAMP)**. - Hormones like **glucagon** and **epinephrine** often utilize this pathway, which is distinct from CCK's primary signaling. *Opening of ion channels* - While ion channels are crucial for many cellular processes, CCK's direct mechanism of action typically involves **intracellular second messengers** rather than direct gating of ion channels. - Neurotransmitters like **acetylcholine** can directly open ion channels, but this is not the main signaling pathway for CCK. *Transcription factors* - Transcription factors regulate **gene expression** by binding to DNA, which is a slower, more long-term cellular response. - While CCK can eventually influence gene expression, its direct and immediate effects (e.g., gallbladder contraction) are mediated by **rapid second messenger systems**, not primary transcription factor modulation.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free